期刊文献+

Ocular Manifestations in Rheumatoid Arthritis

Ocular Manifestations in Rheumatoid Arthritis
下载PDF
导出
摘要 Rheumatoid arthritis (RA) is the most common autoimmune disease. Ocular manifestations of this autoimmune disease vary and are mainly keratoconjunctivitis sicca, episcleritis, scleritis and keratitis. Their appearance, as well as their severity are related to RA chronicity and resistance to therapy. The treatment consists of corticosteroids, NSAIDs and cytotoxic drugs, depending on the type of ocular manifestations and the patient’s response to treatment. Rheumatoid arthritis (RA) is the most common autoimmune disease. Ocular manifestations of this autoimmune disease vary and are mainly keratoconjunctivitis sicca, episcleritis, scleritis and keratitis. Their appearance, as well as their severity are related to RA chronicity and resistance to therapy. The treatment consists of corticosteroids, NSAIDs and cytotoxic drugs, depending on the type of ocular manifestations and the patient’s response to treatment.
作者 Diamantis Almaliotis Marina Zakalka Antony Gerofotis Kleopas Chatzicharalampous Maria Efstathiou Michael Daniilidis Vasileios Karampatakis Diamantis Almaliotis;Marina Zakalka;Antony Gerofotis;Kleopas Chatzicharalampous;Maria Efstathiou;Michael Daniilidis;Vasileios Karampatakis(Laboratory of Experimental Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece;1st Department of Pathology of ΑHΕΠΑ Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece;Department of Haematology, Theageneio Anticancer Hospital, Thessaloniki, Greece)
出处 《Open Journal of Ophthalmology》 2016年第3期170-175,共6页 眼科学期刊(英文)
关键词 Rheumatoid Arthritis Ocular Manifestations AUTOIMMUNITY Nodules Red Eye SICCA SCLERITIS Episcleritis Schirmer’s Test CORTICOSTEROIDS KERATITIS Rheumatoid Arthritis Ocular Manifestations Autoimmunity Nodules Red Eye Sicca Scleritis Episcleritis Schirmer’s Test Corticosteroids Keratitis
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部